Differences in biological properties of tumor-initiating cancer stem cells in squamous cell carcinoma compared to lung or breast adenocarcinoma have been suggested as an explanation to the different observed associations between SOX2 gene amplifications and prognosis [45]. The gene discussed is SOX2; the disease is squamous cell carcinoma.